Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Marks Next Step in Global Expansion with Launch of Its E-Commerce Platform in the UK

PlantX is celebrating the expansion of its e-commerce platform to the United Kingdom The platform will offer a wide array of plant-based products, indoor plants, and educational resources The UK is the leading market for plant-based alternatives in Europe and has in the recent past witnessed changes that align perfectly with PlantX’s recent move The […]

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Discusses Psychedelics Research, Life Sciences Focus, at Key Industry Conferences

MINDCURE President and CEO Kelsey Ramsden will participate in, and has already attended multiple industry conferences throughout December Participation in #CanndoraConnect: Women in Psychedelics Conference focused on exploring job opportunities in psychedelics Company remains focused on promoting healing and improving mental health via digital therapeutics technology and psychedelic compounds research Company reports that 971 million […]

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Upcoming R&D Programs Targeting Global Markets Totaling Over $160 Billion

Lexaria Bioscience plans to launch approximately 12 applied research and development programs in 2022 The programs are designed to explore the ability of the company’s patented DehydraTECH(TM) to improve drug delivery processes for multiple indications Research will continue into the use of DehydraTECH-CBD for high blood pressure, as well as the technology’s potential for oral […]

SPYR Inc. (SPYR) Is ‘One to Watch’

Applied Magix is currently shipping five products to customers The company plans to add new products to its offerings in 2022 Applied Magix is positioned to take advantage of unmet demand for Apple-compatible smart home and connected car products The global smart home market is forecast to hit more than $187 billion in revenue by […]

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) New Patent Application Offering Improved Delivery Control, Enhanced Shelf Stability, of Psilocin

The full patent application covers multiple families of psilocin analogs. Psilocin is the active metabolite of psilocybin In addition to improving delivery control, the company’s dermal application route can potentially eliminate undesirable side effects such as nausea Mydecine appoints Dr. Saeid Babaei, PhD, as an independent board member. The appointment can help advance the company’s […]

FingerMotion Inc. (FNGR) Research Agreement with Munich Re Sets Stage for Predictive Insurance Analysis Growth

Rich communication services (“RCS”) provider and big data analysis solutions developer FingerMotion has announced an agreement with Munich Re to form a collaborative research alliance to benefit life and health insurance risk evaluation FingerMotion focuses its SMS, MMS, and big data products on China’s huge high-end phone consumer market The company’s most recent quarterly report […]

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Proceed with its Phase 2a Fibromyalgia Study Following FDA Confirmation

Tryp just announced FDA confirmation for its IND application filed in November 2021 The confirmation allows the company to proceed with its Phase 2a study on the effectiveness of psilocybin-assisted therapy among patients with fibromyalgia This clinical study will be one of the first to evaluate synthetic psilocybin for fibromyalgia in a Phase 2 study […]

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Fund, Support First-Ever Psychedelic Treatment Clinic at Manhattan Hospital

Company receives grant to fund clinic for marginalized, underserved NYC communities New clinic will offer psychedelic treatment with no out-of-pocket cost for individuals unable to afford the service Program’s clinicians will receive specialized training Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones in its mission […]

American Cannabis Partners’ Strict Adherence to Jamaican Cultivation Techniques Results in Much Sought-After Flower

Jamaican cannabis has benefitted from burgeoning global demand in 2021, with the regulator issuing 42 export licenses American Cannabis Partners has sought to capitalize on growing demand for Jamaican cannabis through a strict adherence to Jamaican cultivation techniques given its close links to the nation US cannabis cultivators are gradually increasing their focus on product […]

 

From Our Blog

GlobalTech Corporation (GLTK) Advances Global Retail Expansion Through Planned Moda in Pelle Acquisition, Supporting AI-Driven Growth Strategy

December 31, 2025

GlobalTech Corporation (OTC: GLTK) is entering a new phase of growth as they recently acquired 123 Investments Limited, doing business as Moda in Pelle (“MIP”). The proposed transactions align with the company’s strategic approach of expanding AI and data-driven capabilities into global consumer retail, positioning technology as a driver of long-term value creation and operational […]

Rotate your device 90° to view site.